Synopsis
Dr Lal PathLabs Ltd experienced a breakout from an inverse Head & Shoulder pattern, indicating a potential trend reversal. Experts recommend short-to-medium term traders to buy on dips, targeting above Rs 3,700. The stock has rebounded multiple times, most recently climbing above Rs 3,000 in July 2024, suggesting stronger support and potential upward momentum.
Dr Lal PathLabs Ltd, part of the healthcare sector, recorded a breakout from inverse Head & Shoulder pattern on the monthly charts which has opened room for the stock to head higher.Short-to-medium term traders can look to buy the stock on dips for a possible target of above Rs 3,700 levels in the next few months, suggest experts.The healthcare stock which has a market capitalization of more than Rs 25,000 cr on the BSE hit a record high of Rs
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. Youβre just a step away.
Why ?
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
-
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
-
Clean experience with
Minimal Ads -
Comment & Engage with ET Prime community -
Exclusive invites to Virtual Events with Industry Leaders -
A trusted team of Journalists & Analysts who can best filter signal from noise -
βGet 1 Year Complimentary Subscription of TOI+ worth Rs.799/-β
Source link
